(FN) Fabrinet - Ratings and Ratios
Optical Components, Transceivers, Lasers, Sensors, Glass Products
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 66.3% |
| Value at Risk 5%th | 96.1% |
| Relative Tail Risk | -11.85% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.28 |
| Alpha | 61.88 |
| CAGR/Max DD | 1.30 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.383 |
| Beta | 1.919 |
| Beta Downside | 1.899 |
| Drawdowns 3y | |
|---|---|
| Max DD | 37.47% |
| Mean DD | 11.54% |
| Median DD | 10.21% |
Description: FN Fabrinet January 04, 2026
Fabrinet (NYSE:FN) is a contract manufacturer that specializes in optical packaging and precision electro-mechanical and electronic services across North America, APAC, and Europe. Its end-to-end capabilities span process design, supply-chain management, PCB assembly, integration, final testing, and high-volume production of complex optical components.
The product portfolio includes reconfigurable optical add-drop multiplexers (ROADMs), optical amplifiers, modulators, transceivers, tunable lasers, and active optical cables that support high-speed interconnects for data-center and computing-cluster applications (e.g., Infiniband, Ethernet, Fibre Channel). Fabrinet also produces a range of lasers (solid-state, diode-pumped, gas, fiber) for semiconductor, biotech, and metrology markets, as well as sensors (differential pressure, micro-gyro, fuel) for automotive and medical devices, and custom optical glass components (crystals, lenses, prisms, fused silica).
Key financial and market metrics (FY 2023): revenue of roughly **$1.3 billion**, an adjusted EBITDA margin of **~8 %**, and a **~12 %** year-over-year growth rate driven largely by rising data-center demand and 5G infrastructure roll-outs. The EMS sector is currently benefitting from a **global telecom-capex surge** (estimated $1.2 trillion in 2024) and a **tight supply of advanced optical components**, which together create a favorable tailwind for Fabrinet’s high-mix, high-value contracts.
Fabrinet’s customer base is diversified across OEMs of optical communication modules, industrial lasers, automotive sensors, and medical devices, reducing reliance on any single end-market. However, the company remains exposed to **cyclical semiconductor and telecom spending**, and to **geopolitical supply-chain risks** in the Asia-Pacific region.
For a deeper dive into FN’s valuation metrics and peer comparison, you might explore the ValueRay platform.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (348.1m TTM) > 0 and > 6% of Revenue (6% = 215.6m TTM) |
| FCFTA 0.07 (>2.0%) and ΔFCFTA -5.38pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 46.02% (prev 51.07%; Δ -5.05pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.12 (>3.0%) and CFO 347.8m <= Net Income 348.1m (YES >=105%, WARN >=100%) |
| Net Debt (-299.8m) to EBITDA (431.4m) ratio: -0.70 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.83 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (36.1m) change vs 12m ago -0.85% (target <= -2.0% for YES) |
| Gross Margin 11.99% (prev 12.35%; Δ -0.36pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 131.9% (prev 123.1%; Δ 8.84pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| error: Interest Coverage Ratio cannot be calculated (needs EBITDA TTM and Interest Expense TTM) |
Altman Z'' 9.34
| (A) 0.55 = (Total Current Assets 2.56b - Total Current Liabilities 905.5m) / Total Assets 3.01b |
| (B) 0.73 = Retained Earnings (Balance) 2.19b / Total Assets 3.01b |
| (C) 0.14 = EBIT TTM 375.9m / Avg Total Assets 2.72b |
| (D) 2.32 = Book Value of Equity 2.20b / Total Liabilities 947.6m |
| Total Rating: 9.34 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 71.70
| 1. Piotroski 4.50pt |
| 2. FCF Yield 1.27% |
| 3. FCF Margin 5.60% |
| 4. Debt/Equity 0.00 |
| 5. Debt/Ebitda -0.70 |
| 6. ROIC - WACC (= 5.26)% |
| 7. RoE 17.87% |
| 8. Rev. Trend 98.14% |
| 9. EPS Trend -5.08% |
What is the price of FN shares?
Over the past week, the price has changed by -6.71%, over one month by -10.28%, over three months by +17.00% and over the past year by +95.85%.
Is FN a buy, sell or hold?
- Strong Buy: 3
- Buy: 2
- Hold: 4
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the FN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 492.7 | 10.2% |
| Analysts Target Price | 492.7 | 10.2% |
| ValueRay Target Price | 685.8 | 53.3% |
FN Fundamental Data Overview January 10, 2026
P/S = 4.4164
P/B = 7.6992
P/EG = 1.19
Beta = 1.035
Revenue TTM = 3.59b USD
EBIT TTM = 375.9m USD
EBITDA TTM = 431.4m USD
Long Term Debt = 5.16m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 1.86m USD (from shortTermDebt, last quarter)
Debt = 5.16m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -299.8m USD (from netDebt column, last quarter)
Enterprise Value = 15.87b USD (15.87b + Debt 5.16m - CCE 2.85m)
Interest Coverage Ratio = unknown (Ebit TTM 375.9m / Interest Expense TTM 0.0)
EV/FCF = 78.91x (Enterprise Value 15.87b / FCF TTM 201.1m)
FCF Yield = 1.27% (FCF TTM 201.1m / Enterprise Value 15.87b)
FCF Margin = 5.60% (FCF TTM 201.1m / Revenue TTM 3.59b)
Net Margin = 9.69% (Net Income TTM 348.1m / Revenue TTM 3.59b)
Gross Margin = 11.99% ((Revenue TTM 3.59b - Cost of Revenue TTM 3.16b) / Revenue TTM)
Gross Margin QoQ = 11.90% (prev 12.23%)
Tobins Q-Ratio = 5.28 (Enterprise Value 15.87b / Total Assets 3.01b)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 5.16m)
Taxrate = 5.42% (5.50m / 101.4m)
NOPAT = 355.5m (EBIT 375.9m * (1 - 5.42%))
Current Ratio = 2.83 (Total Current Assets 2.56b / Total Current Liabilities 905.5m)
Debt / Equity = 0.00 (Debt 5.16m / totalStockholderEquity, last quarter 2.06b)
Debt / EBITDA = -0.70 (Net Debt -299.8m / EBITDA 431.4m)
Debt / FCF = -1.49 (Net Debt -299.8m / FCF TTM 201.1m)
Total Stockholder Equity = 1.95b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.78% (Net Income 348.1m / Total Assets 3.01b)
RoE = 17.87% (Net Income TTM 348.1m / Total Stockholder Equity 1.95b)
RoCE = 19.24% (EBIT 375.9m / Capital Employed (Equity 1.95b + L.T.Debt 5.16m))
RoIC = 18.24% (NOPAT 355.5m / Invested Capital 1.95b)
WACC = 12.99% (E(15.87b)/V(15.87b) * Re(12.99%) + D(5.16m)/V(15.87b) * Rd(0.0%) * (1-Tc(0.05)))
Discount Rate = 12.99% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.74%
[DCF Debug] Terminal Value 66.77% ; FCFF base≈238.4m ; Y1≈294.1m ; Y5≈500.8m
Fair Price DCF = 124.4 (EV 4.16b - Net Debt -299.8m = Equity 4.46b / Shares 35.8m; r=12.99% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -5.08 | EPS CAGR: -43.22% | SUE: -4.0 | # QB: 0
Revenue Correlation: 98.14 | Revenue CAGR: 15.67% | SUE: 4.0 | # QB: 4
EPS next Quarter (2026-03-31): EPS=3.44 | Chg30d=+0.003 | Revisions Net=+7 | Analysts=8
EPS current Year (2026-06-30): EPS=13.25 | Chg30d=+0.007 | Revisions Net=+7 | Growth EPS=+30.3% | Growth Revenue=+28.0%
EPS next Year (2027-06-30): EPS=15.31 | Chg30d=+0.049 | Revisions Net=+5 | Growth EPS=+15.5% | Growth Revenue=+13.9%
Additional Sources for FN Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle